« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2
, Pages 422-433
, 1 June 2002
Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema
References
- American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:789–799
-
American Brachytherapy Society survey of current clinical practice for permanent brachytherapy of prostate cancer.
J Brachytherapy Int. 1997;13:243–251
- . Permanent implants using Au-198, Pd-103 and I-125 (Radiobiological considerations based on the linear quadratic model). Int J Radiat Oncol Biol Phys. 1992;23:81–87
- Transperineal iodine-125 seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol. 1983;130:283–286
-
.
The effect of edema on postimplant dosimetry of permanent iodine-125 prostate implants (A simulation study).
J Brachytherapy Int. 1998;14:225–231
- Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1997;37:927–933
- Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry (An analysis based on serial CT acquisition). Int J Radiat Oncol Biol Phys. 1998;41:1069–1077
- . Effect of tumour shrinkage on the biological effectiveness of permanent brachytherapy implants. Br J Radiol. 1994;67:639–645
- . CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1997;39:347–353
- A CT-based evaluation method for permanent implants (Application to prostate). Int J Radiat Oncol Biol Phys. 1993;26:163–169
-
.
Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early-stage prostate cancer (Technical concepts in planning, operative technique, and evaluation).
Atlas Urol Clin North Am. 1994;2:113–125
- Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. Int J Radiat Oncol Biol Phys. 1997;37:1181–1185
- Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. Int J Radiat Oncol Biol Phys. 1997;39:341–346
- Optimum timing for image-based dose evaluation of I-125 and Pd-103 prostate seed implants. Int J Radiat Oncol Biol Phys. 1999;45:1063–1072
- Dosimetric effects of edema in permanent prostate seed implants (A rigorous solution). Int J Radiat Oncol Biol Phys. 2000;47:1405–1419
- . Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982;8:1981–1997
- . The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol. 1985;58:515–528
- . Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model. Br J Radiol. 1989;62:241–244
- . A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of I-125 and Pd-103. Phys Med Biol. 2001;46:2557–2569
- . The assessment of RBE effects using the concept of biologically effective dose. Int J Radiat Oncol Biol Phys. 1999;43:639–645
- (GRP) Dosimetry of interstitial brachytherapy sources (Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43). Med Phys. 1995;22:209–234
- . Is α/β for prostate tumors really low?. Int J Radiat Oncol Biol Phys. 2001;50:1021–1031
- . What is the Tpot for prostate cancer? Radiobiological implications of the equivalent outcome with I-125 or Pd-103. Int J Radiat Oncol Biol Phys. 2000;47:1165–1167
- . Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:1095–1101
- Isotope selection for permanent prostate implants? An evaluation of Pd-103 versus I-125 based on radiobiological effectiviness and dosimetry. Semin Urol Oncol. 2000;18:152–159
- Cell kinetic measurements in prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:1067–1070
☆ Supported by the J. A. Cohen Institute for Radiopathology and Radiation Protection, Leiden, The Netherlands.
PII: S0360-3016(02)02755-4
© 2002 Elsevier Science Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2
, Pages 422-433
, 1 June 2002
